Cann Group Ltd (ASX: CAN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cann Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$20.36 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
536.09 million
Earnings per share
-0.113
Dividend per share
N/A
Year To Date Return
-58.59%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cann Group Ltd (ASX: CAN)
Latest News
Cannabis Shares
ASX cannabis stocks eyeing $1 billion domestic market
Cannabis Shares
2 ASX cannabis shares with big news today
Cannabis Shares
Could ASX cannabis shares be set for a smoking hot rebound?
Cannabis Shares
Could ASX cannabis shares be set for a resurgence?
Cannabis Shares
Why ASX cannabis shares just jumped back into the spotlight
Cannabis Shares
Buying ASX cannabis stocks? Here's what the Victorian government is considering right now
Cannabis Shares
Looking to buy ASX cannabis shares right now? You'll want to watch this
Share Fallers
Why Ampol, Cann, Reliance Worldwide, and South32 shares are dropping
Cannabis Shares
Why is everyone talking about ASX cannabis shares all of a sudden?
Cannabis Shares
Why are these 2 ASX cannabis shares booming all of a sudden?
Cannabis Shares
Can ASX cannabis shares ever fully recover?
Share Gainers
Why Argosy Minerals, Cann, OZ Minerals, and PointsBet shares are pushing higher
CAN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cann Group Ltd
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
CAN Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 20 Dec 2024 | $0.04 | $0.00 | 0.00% | 192,452 | $0.04 | $0.04 | $0.04 |
| 19 Dec 2024 | $0.04 | $0.00 | 0.00% | 285,626 | $0.04 | $0.04 | $0.04 |
| 18 Dec 2024 | $0.04 | $0.00 | 0.00% | 211,555 | $0.04 | $0.04 | $0.04 |
| 17 Dec 2024 | $0.04 | $0.00 | 0.00% | 85,422 | $0.04 | $0.04 | $0.04 |
| 16 Dec 2024 | $0.04 | $0.00 | 0.00% | 1,845,324 | $0.04 | $0.04 | $0.04 |
| 13 Dec 2024 | $0.04 | $0.00 | 0.00% | 190,431 | $0.04 | $0.04 | $0.04 |
| 12 Dec 2024 | $0.04 | $0.00 | 0.00% | 78,058 | $0.04 | $0.04 | $0.04 |
| 11 Dec 2024 | $0.04 | $0.00 | 0.00% | 108,135 | $0.04 | $0.04 | $0.04 |
| 10 Dec 2024 | $0.04 | $0.00 | 0.00% | 84,525 | $0.04 | $0.04 | $0.04 |
| 09 Dec 2024 | $0.04 | $0.00 | 0.00% | 330,870 | $0.04 | $0.04 | $0.04 |
| 06 Dec 2024 | $0.04 | $0.00 | 0.00% | 1,524,124 | $0.04 | $0.04 | $0.04 |
| 05 Dec 2024 | $0.04 | $0.00 | 0.00% | 876,020 | $0.04 | $0.04 | $0.04 |
| 04 Dec 2024 | $0.04 | $0.00 | 0.00% | 522,920 | $0.04 | $0.04 | $0.04 |
| 03 Dec 2024 | $0.04 | $0.00 | 0.00% | 752,027 | $0.04 | $0.04 | $0.04 |
| 02 Dec 2024 | $0.04 | $0.00 | 0.00% | 1,253,367 | $0.05 | $0.05 | $0.04 |
| 29 Nov 2024 | $0.05 | $0.00 | 0.00% | 421,984 | $0.05 | $0.05 | $0.05 |
| 28 Nov 2024 | $0.05 | $0.00 | 0.00% | 494,195 | $0.05 | $0.05 | $0.05 |
| 27 Nov 2024 | $0.05 | $0.00 | 0.00% | 960,770 | $0.04 | $0.05 | $0.04 |
| 26 Nov 2024 | $0.04 | $0.00 | 0.00% | 318,988 | $0.05 | $0.05 | $0.04 |
| 25 Nov 2024 | $0.04 | $0.00 | 0.00% | 170,654 | $0.05 | $0.05 | $0.04 |
| 22 Nov 2024 | $0.05 | $0.00 | 0.00% | 252,920 | $0.05 | $0.05 | $0.05 |
| 21 Nov 2024 | $0.05 | $0.00 | 0.00% | 98,577 | $0.05 | $0.05 | $0.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 02 Dec 2024 | Jennifer (Jenni) Pilcher | Issued | 110,167 | $4,406 |
Rights issue.
|
| 02 Dec 2024 | Douglas (Doug) Rathbone | Issued | 60,000 | $2,400 |
Rights issue.
|
| 02 Dec 2024 | Julian Chick | Issued | 83,334 | $3,333 |
Rights issue.
|
| 02 Dec 2024 | Robert Barnes | Issued | 66,667 | $2,666 |
Rights issue.
|
| 15 Nov 2024 | Julian Chick | Issued | 600,000 | $27,000 |
Issue of securities.
|
| 15 Nov 2024 | Jennifer (Jenni) Pilcher | Issued | 4,500,000 | $202,500 |
Issue of securities.
|
| 15 Nov 2024 | Douglas (Doug) Rathbone | Issued | 300,000 | $13,500 |
Issue of securities.
|
| 15 Nov 2024 | Robert Barnes | Issued | 300,000 | $13,500 |
Issue of securities.
|
| 12 Jun 2024 | Jennifer (Jenni) Pilcher | Buy | 205,500 | $9,952 |
On-market trade.
|
| 05 Jun 2024 | Robert Barnes | Buy | 200,000 | $10,000 |
On-market trade.
|
| 04 Jun 2024 | Julian Chick | Buy | 250,000 | $10,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Douglas (Doug) John Rathbone | Non-Executive Director | Mar 2015 |
Mr Rathbone is a public company director. He is the Chairman of the Rathbone Wine Group, Director of Cotton Seed Distributors, Go Resources, AgBiTech. He is also a Chairman of Health Food Holdings and Delta Agribusiness Pty Ltd. Doug is an Honorary Life Governor of the Royal Children's Hospital. He is President of My Room Children's Cancer Charity Limited and founder of Children's Cancer Foundation.
|
| Mr Allan D McCallum | Non-Executive ChairmanNon-Executive Director | Jan 2015 |
Mr McCallum has experience as a public company director in agribusiness and healthcare who has ethics, leadership capabilities and experience in strategy development and implementation, and mergers and acquisitions. Allan is also a member of Rabobank Australia Limited's Advisory Board (wholesale banking).
|
| Dr Julian John Chick | Non-Executive DirectorNon-Executive Deputy Chairman | Oct 2022 |
Dr Chick has over 25 years of experience in the biotechnology and medical technology sectors, as well as in investment banking. He has worked with public and private companies, bringing several technologies through from discovery to market, as well as experience in capital raisings, company restructuring, licensing, business development and M&A transactions. He is a member of the Risk Committee.
|
| Ms Jennifer (Jenni) Pilcher | Chief Executive OfficerManaging Director | Sep 2020 |
Ms Pilchers has over 15 years of senior finance executive experience in the medical, biotechnology and technology sectors, within small-mid cap ASX-listed companies. In addition to financial management, investor relations and corporate governance experience. Most recently, Jenni was Chief Financial Officer & Company Secretary of technology communications company Whispir Ltd (ASX:WSP), and prior to that was CFO & Company Secretary of digital imaging company, Mach7 Technologies (ASX:M7T). She has also previously held CFO roles with Australia biotechnology companies Alchemia Limited (ASX:ACL) and Mesoblast Limited (ASX:MSB).
|
| Mr Robert Gordon Barnes | Non-Executive Director | Sep 2022 |
Mr Barnes is an executive who has delivered leadership and operational outcomes across a variety of healthcare industries, including pharmaceutical, nutraceutical, infant formula, consumer, medical devices, and diagnostics. Having worked globally and in Australia in healthcare organizations, he brings diverse commercial and scientific understanding to the Company. Robert has held senior executive roles at several pharmaceutical and consumer healthcare entities including Aspen Pharmacare Australia Pty Ltd, Sanofi Australia, and Mayne Group. He has experience in the medicinal cannabis sector, being a former member of the advisory board to Leafcann Group Pty Ltd. He is Chair of the Risk Committee.
|
| Mr Steven Notaro | Company Secretary | May 2024 |
-
|
| Tony Di Pietro | Chief Financial Officer |
-
|
|
| Steven Notaro | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Ryan Prue | 14,000,000 | 3.00% |
| Mr Philip Jacobsen & Mrs Maxine Jacobsen | 11,478,943 | 2.46% |
| Mullacam Pty Ltd | 7,296,023 | 1.56% |
| Flag Capital Pty Ltd | 5,876,453 | 1.26% |
| Mr Jiashun Yang | 5,253,000 | 1.12% |
| Citicorp Nominees Pty Limited | 4,663,983 | 1.00% |
| Supernova Fund Pty Ltd | 4,341,363 | 0.93% |
| Invia Custodian Pty Limited | 4,040,000 | 0.86% |
| Adsd Soodin Holdings Pty Ltd | 3,865,051 | 0.83% |
| Ms Shengyan Hu & Mr Xiangjun Zhao | 3,550,000 | 0.76% |
| Mr Christopher John Page | 3,500,000 | 0.75% |
| T R Samuels Transport Pty Limited | 3,305,817 | 0.71% |
| Cmc Markets Stockbroking Nominees Pty Limited | 3,187,043 | 0.68% |
| Mr Michael Anderson | 2,524,620 | 0.54% |
| Hsbc Custody Nominees (Australia) Limited | 2,475,884 | 0.53% |
| Mr Xuelong Sun | 2,463,750 | 0.53% |
| Commonwealth Scientific And Industrial Research Organisation | 2,450,338 | 0.52% |
| Pacific Custodians Pty Limited | 2,183,068 | 0.47% |
| Hardmail Pty Ltd | 2,150,000 | 0.46% |
| Finclear Services Pty Ltd | 1,906,633 | 0.40% |
